89bio, Inc. Deferred Tax Assets, Other
89bio, Inc. had Deferred Tax Assets, Other of $1.06 million as of 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2025-02-27
- 2024-12-31: Deferred Tax Assets, Other $1.06M.
- 2023-12-31: Deferred Tax Assets, Other $378.00K.
- 2022-12-31: Deferred Tax Assets, Other $244.00K.
- 2021-12-31: Deferred Tax Assets, Other $191.00K.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2024-12-31 | $1.06M 10-K · filed 2025-02-27 | |
| 2023-12-31 | $378.00K 10-K · filed 2025-02-27 | |
| 2022-12-31 | $244.00K 10-K · filed 2024-03-01 | |
| 2021-12-31 | $191.00K 10-K · filed 2023-03-15 | |
| 2020-12-31 | $48.00K 10-K · filed 2022-03-24 | $658.00K 10-K · filed 2021-03-25 |
| 2019-12-31 | $10.00K 10-K · filed 2021-03-25 | $451.00K 10-K · filed 2020-03-18 |
| 2018-12-31 | $20.00K 10-K · filed 2020-03-18 |